High Court Rules in Favor of Lethal Injection, But Throws the Debate Wide Open

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


The Supreme Court this morning ruled that lethal injection is not “cruel and unusual punishment,” at least not in Kentucky, that is. The case under review, Baze v. Rees, originated from the appeals of two death row inmates in Kentucky and will likely end the nation’s de-facto death penalty moratorium by establishing the standard with which states can determine whether their lethal injection protocol violates the Constitution.

But despite the Court’s 7-2 decision, there are strong indications that the debate surrounding lethal injection is nowhere near over and in fact the case may be a springboard for new challenges to capital punishment. The Court’s opinion was badly splintered with no opinion garnering more than three votes, which means that while the majority of justices agreed that Kentucky’s procedure was not unconstitutional, they did not agree on the reasons why. Justice John Paul Stevens, although he voted with the majority, issued his own opinion stating,

Instead of ending the controversy, I am now convinced that this case will generate debate not only about the constitutionality of the three-drug protocol, and specifically about the justification for the use of the paralytic agent, pancuronium bromide, but also about the justification for the death penalty itself.

As Justice Stevens noted, pancuronium bromide, the second drug administered during lethal injection’s three-drug procedure, is likely to remain at the center of the firestorm.

A chemical that induces paralysis, pancuronium bromide can mask the signs of a painfully botched execution. In fact, its risks are so grave that 42 states ban its use for animal euthanasia. In his report released earlier this month, Ty Alper, associate director of UC Berkeley’s Death Penalty Clinic, notes that nearly 98% of all lethal injections which used pancuronium brodmide to kill a human being took place in states where the law says it’s inhumane to use the same or similar drugs to kill an animal.

Even the justices who signed on to the main opinion upholding lethal injection seem to understand the risks of the drugs currently used, and the potential for improvement. Justice Roberts, writing for the plurality, made clear that if alternative methods are proposed that are “feasible, readily implemented, and in fact substantially reduce” the risk of harm, a state would be violating the Constitution by not switching to them.

But the thing is, no hard evidence about such an alternative was presented in Kentucky’s Baze v. Rees, so the justices could not choose a better procedure for Kentucky’s death chamber. However, evidence that those alternatives exist abounds in other cases that originated in different states. For example, experts on both sides of the debate in Tennessee conceded as much, citing death by barbiturate as an effective and humane option. But the justices couldn’t consider Tennessee’s evidence because they were limited to Kentucky’s. Commenting on today’s opinion, Alper said, “In states where evidence of these procedures is introduced, unlike in the Baze case, it is reasonable to assume that the state’s refusal to adopt those procedures will not be tolerated.” In other words, lethal injection challenges will not cease with today’s ruling and the debate about how to execute people, or whether to execute them at all, will certainly continue in states beyond Kentucky.

—Celia Perry

OUR DEADLINE MATH PROBLEM

It’s risky, but also unavoidable: A full one-third of the dollars that we need to pay for the journalism you rely on has to get raised in December. A good December means our newsroom is fully staffed, well-resourced, and on the beat. A bad one portends budget trouble and hard choices.

The December 31 deadline is drawing nearer, and if we’re going to have any chance of making our goal, we need those of you who’ve never pitched in before to join the ranks of MoJo donors.

We simply can’t afford to come up short. There is no cushion in our razor-thin budget—no backup, no alternative sources of revenue to balance our books. Corporations and powerful people with deep pockets will never sustain the fierce journalism we do. That’s why we need you to show up for us right now.

payment methods

OUR DEADLINE MATH PROBLEM

It’s risky, but also unavoidable: A full one-third of the dollars that we need to pay for the journalism you rely on has to get raised in December. A good December means our newsroom is fully staffed, well-resourced, and on the beat. A bad one portends budget trouble and hard choices.

The December 31 deadline is drawing nearer, and if we’re going to have any chance of making our goal, we need those of you who’ve never pitched in before to join the ranks of MoJo donors.

We simply can’t afford to come up short. There is no cushion in our razor-thin budget—no backup, no alternative sources of revenue to balance our books. Corporations and powerful people with deep pockets will never sustain the fierce journalism we do. That’s why we need you to show up for us right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate